Cited by 112Microbial Metabolites in Food BiotechnologyGut microbiota and healthProbiotics and Fermented Foods

High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome

Open access
Monteagudo-Mera, A., Arthur, J.C., Jobin, C., Keku, T., Bruno-Barcena, J.M., Azcarate-Peril, M.A.·2016·Beneficial Microbes

Abstract

Prebiotics are selectively fermented ingredients that result in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon the host health. The aim of this study was to evaluate the influence of a β(1-4)galacto-oligosaccharides (GOS) formulation consisting of 90% pure GOS (GOS90), on the composition and activity of the mouse gut microbiota. Germ-free mice were colonised with microbiota from four pathogen-free wt 129 mice donors (SPF), and stools were collected during a feeding trial in which GOS90 was delivered orally for 14 days. Pyrosequencing of 16S rDNA amplicons showed that Bifidobacterium and specific Lactobacillus , Bacteroides and Clostridiales were more prevalent in GOS90-fed mice after 14 days, although the prebiotic impact on Bifidobacterium varied among individual mice. Prebiotic feeding also resulted in decreased abundance of Bacteroidales, Helicobacter and Clostridium. High-throughput quantitative PCR showed an increased abundance of Bifidobacterium adolescentis, Bifidobacterium pseudocatenulatum, Bifidobacterium lactis and Bifidobacterium gallicum in the prebiotic-fed mice. Control female mice showed a higher diversity (phylogenetic diversity (PD) = 15.1±3.4 in stools and PD = 13.0±0.6 in intestinal contents) than control males (PD = 7.8±1.6 in stool samples and PD = 9.5±1.0 in intestinal contents). GOS90 did not modify inflammatory biomarkers (interleukin (IL)-6, IL-12, IL-1β, interferon gamma and tumour necrosis factor alpha). Decreased butyrate, acetate and lactate concentrations in stools of prebiotic fed mice suggested an increase in colonic absorption and reduced excretion. Overall, our results demonstrate that GOS90 is capable of modulating the intestinal microbiome resulting in expansion of the probiome (autochtonous commensal intestinal bacteria considered to have a beneficial influence on health).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3920/bm2015.0114

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous studies have demonstrated the capability of prebiotics to promote bifidobacterial presence within the microbiota, correlating with other changes in the overall microbiota composition and metabolism.

    “On the other hand, numerous studies have demonstrated the capability of prebiotics to promote bifidobacterial presence within the microbiota, correlating with other changes in the overall microbiota composition and metabolism.”

    From Bifidobacteria and Their Health-Promoting Effects (2017) · cites this paper as [52]

  • In vitro and in vivo studies have shown that modulating bifidobacterial levels through probiotic or prebiotic supplementation can change the overall composition and metabolism of the gut microbiota.

    “In vitro and in vivo studies have shown that modulating bifidobacterial levels through probiotic or prebiotic supplementation can change the overall composition and metabolism of the gut microbiota (49–53).”

    From Bifidobacteria and Their Health-Promoting Effects (2017) · cites this paper as [52]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [12]Tzortzis G Vulevic J Charalampopoulos D RA R Galacto-oligosaccharide Prebiotics and Probiotics: Science and Technology 2009 Guildford Springer 207 243
  2. [22]Sangwan V Tomar SK Singh RR Singh AK Ali B Galactooligosaccharides: novel components of designer foods J Food Sci 2011 76 R103 R111 22417365
  3. [26]Dagher SF Azcarate-Peril MA Bruno-Barcena JM Heterologous expression of a bioactive beta-hexosyltransferase, an enzyme producer of prebiotics, from Sporobolomyces singularis Appl Environ Microbiol 2013 79 1241 1249 23241974 PMC3568590
  4. [42]Hermann-Bank ML Skovgaard K Stockmarr A Larsen N Molbak L The Gut Microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity BMC Genomics 14 788 24225361 PMC3879714
  5. [46]Junick J Blaut M Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene Appl Environ Microbiol 2012 78 2613 2622 22307308 PMC3318781
  6. [68]Gopal PK Ramsay R Sullivan PA Smart JB Growth promoting effects of galactooligosaccharides on B. lactis HN010 (DR10) and L. rhamnosus HN001 (DR20) American Journal of Clinical Nutrition 2001 73 496S 496S

Cited by

Sorted by citations

Authors
Monteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Department of Plant and Microbial Biology, 4550A Thomas Hall, Campus Box 7615, Raleigh, NC 27695, USA
  • Microbiome Core Facility, Center for Gastrointestinal Biology and Disease, University of North Carolina, 312 Isaac Taylor Hall, Chapel Hill, NC 27599, USA
Venue
Beneficial Microbes
Published
2016
Volume
7
Issue
2
Pages
247-264
ISSN
  • 1876-2883 (ISSN-L)
  • 1876-2891
OpenAlex
W2262506242
Cited by
112
References
91
Citations by year
2026: 5 · 2025: 6 · 2024: 14 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 5
FWCI
14.66
Type
journal article
Language
en
Open access
Locations
  • Beneficial Microbes (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK103952, P30‐DK34987, P30DK034987)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
galactooligosaccharides, prebiotics, Bifidobacterium, gut microbiota, germ-free mice, Bifidobacterium adolescentis, Bifidobacterium animalis subsp. lactis, Bifidobacterium pseudocatenulatum, short-chain fatty acids, butyrate, interleukin-6, inflammation, microbial diversity, Clostridiales, Bacteroidales
MeSH terms
Gastrointestinal Microbiome, Animals, Bacteria, Bifidobacterium, Female, Fermentation, Galactose, Male, Oligosaccharides, Interleukin-6, Interleukin-12, Gastrointestinal Tract, Mice, Prebiotics, Mice, 129 Strain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review